1216 J . Org. Chem., Vol. 64, No. 4, 1999
Ueno et al.
room temperature. After 30 min, EtOH (10 mL) was added to
the mixture, and the whole was stirred for 10 min. The mixture
was concentrated in vacuo and was taken in AcOEt, which
was washed with saturated aqueous NaHCO3 and brine. The
separated organic phase was dried (Na2SO4) and concentrated
to dryness. The residue was purified by column chromatog-
raphy (SiO2, 0-5% MeOH in CHCl3) to give 6a 10 (1.48 g, 13%),
6b (10.1 g, 55%), and 6c (7.95 g, 31%). The physical data of
6a : mp 69-72 °C; 1H NMR (CDCl3) δ 7.67-7.37 (m, 10H),
3.72 (d, 6H, J ) 4.8), 3.64 (s, 2H), 2.60 (t, 3H, J ) 4.8, D2O
exchangeable), 1.07 (s, 18H); 13C NMR (CDCl3, 13C signals were
assigned on the basis of DEPT experiment) δ 135.59 (CH),
132.64 (C), 130.03 (CH), 127.91 (CH), 65.32 (CH2), 64.83 (CH2),
45.62 (C), 26.91 (CH3), 19.21 (C); HRMS (FAB) calcd for
C21H31O4Si 375.1990, found 375.1974. Anal. Calcd for C21H30O4-
Si: C, 67.34; H, 8.07. Found: C, 67.44; H, 7.90. The physical
(m, 4H), 3.06 (m, 4H), 2.98 (t, 4H), 1.67 (br s, 4H); 13C NMR
(CDCl3, 13C signals were assigned on the basis of DEPT
experiment) δ 158.4 (C), 157.1 (C), 144.8 (C), 136.1 (C), 129.9
(CH), 128.0 (CH), 127.8 (CH), 126.8 (CH), 113.1 (CH), 86.3 (C),
62.4 (CH2), 61.7 (CH2), 61.5 (CH2), 55.2 (CH3), 46.1 (C), 39.4
(CH3), 29.6 (CH2). Anal. Calcd for C55H62N2O12‚H2O: C, 68.73;
H, 6.71; N, 2.91. Found: C, 68.74; H, 6.51; N, 2.93.
1,3-O-Bis[[[N-[3-O-(4,4′-d im eth oxytr ityloxy)p r op yl]ca r -
b a m oyl]-2,2-b is[[N-(3-h yd r oxyp r op yl)ca r b a m oyl]oxy]-
m eth yl]-1,3-pr opan ediol (10). N,N-Carbonyldiimidazole (6.49
g, 40.0 mmol) and DMAP (120 mg, 1.00 mmol) were added to
a solution of 9 (9.43 g, 10.0 mmol) in DMF (40 mL), and the
mixture was stirred at room temperature. After 40 min,
3-amino-1-propanol (11.5 mL, 150 mmol) was added to the
mixture, and it was stirred at room temperature for 1 h. The
mixture was concentrated in vacuo and was taken in AcOEt,
which was washed with H2O and brine. The separated organic
phase was dried (Na2SO4) and concentrated to dryness. The
residue was purified by column chromatography (SiO2, 1-3%
MeOH in CHCl3) to give 10 (10.4 g, 91%): 1H NMR (DMSO-
d6) δ 7.37-7.20 (m, 18H), 7.09 (br s, 4H, D2O exchangeable),
6.89-6.86 (m, 8H), 4.39 (t, 2H, J ) 5.0, D2O exchangeable),
3.94 (br s, 8H), 3.72 (s, 12H), 3.39 (m, 4H), 3.05-2.97 (m, 12H),
1.66 (m, 4H), 1.54 (m, 4H); 13C NMR (CDCl3, 13C signals were
assigned on the basis of DEPT experiment) δ 158.4 (C), 145.0
(C), 136.2 (C), 129.9 (CH), 128.1 (CH), 127.8 (CH), 126.8 (CH),
113.1 (CH), 86.2 (C), 61.6 (CH2), 59.6 (CH2), 55.2 (CH3), 39.2
(CH2), 38.0 (CH2), 32.3 (CH2), 29.7 (CH2); HRMS (FAB) calcd
for C63H77N4O16 1145.5330, found 1145.5410. Anal. Calcd for
1
data of 6b: mp 85-86 °C; H NMR (CDCl3) δ 7.62-7.32 (m,
20H), 3.75 (d, 4H, J ) 6.0), 3.67 (s, 4H), 2.26 (t, 2H, J ) 6.0,
D2O exchangeable), 1.02 (s, 18H); 13C NMR (CDCl3, 13C signals
were assigned on the basis of DEPT experiment) δ 135.6 (CH),
132.8 (C), 129.9 (CH), 127.8 (CH), 64.8 (CH2), 64.6 (CH2), 46.4
(C), 26.9 (CH3), 19.2 (C); HRMS (FAB) calcd for C37H49O4Si2
613.3167, found 613.3141. Anal. Calcd for C37H48O4Si2: C,
72.50; H, 7.89. Found: C, 72.49; H, 7.84. The physical data of
6c: mp 92-94 °C; 1H NMR (CDCl3) δ 7.58-7.25 (m, 30H), 3.81
(d, 2H, J ) 6.0), 3.74 (s, 6H), 2.78 (t, 1H, J ) 6.0, D2O
exchangeable), 0.96 (s, 27H); 13C NMR (CDCl3, 13C signals were
assigned on the basis of DEPT experiment) δ 135.6 (CH), 132.6
(C), 130.0 (CH), 127.9 (CH), 65.3 (CH2), 64.7 (CH2), 64.6 (CH2),
45.6 (C), 25.9 (CH3), 19.2 (C); HRMS (FAB) calcd for C53H67O4-
Si3 851.4343, found 851.4391. Anal. Calcd for C53H66O4Si3: C,
74.77; H, 7.81. Found: C, 74.76; H, 7.97.
C
63H76N4O16‚3/4H2O: C, 65.30; H, 6.74; N, 4.83. Found: C,
65.23; H, 6.60; N, 4.90.
2,2-Bis[[[N-[3-O-[[â-cya n oeth oxy)(N,N-d iisop r op yla m i-
n o)p h osp h in o]oxy]p r op yl]ca r b a m oyl]oxy]m et h yl]-1,3-
bis[N-[3-O-(4,4′-d im eth oxytr ityloxy)p r op yl]ca r ba m oyl]-
1,3-p r op a n ed iol (11). After successive coevaporation with
pyridine, 10 (458 mg, 0.40 mmol) was dissolved in CH2Cl2 (12
mL) containing N,N-diisopropylethylamine (0.28 mL, 1.60
mmol). 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite
(0.27 mL, 1.20 mmol) was added to the solution, and the
reaction mixture was stirred for 10 min at room temperature.
Aqueous saturated NaHCO3 and CHCl3 were added to the
mixture, and the separated organic layer was washed with
aqueous saturated NaHCO3, brine, dried (Na2SO4), and con-
centrated. The residue was purified by column chromatogra-
phy (neutralized SiO2, AcOEt) to give 11 (400 mg, 65%): 1H
NMR (CDCl3) δ 7.42-6.81 (m, 26H), 5.14 (br s, 2H), 4.98 (br
s, 2H), 4.03 (s, 8H), 3.78 (s, 12H), 3.89-3.42 (m, 12H), 3.26
(m, 8H), 3.16 (t, 4H), 2.63 (t, 4H), 1.78 (m, 8H), 1.19 (d, 12H),
1.17 (d, 12H); 31P NMR (CDCl3) δ 148.51.
Syn th esis of ODNs. ODNs were synthesized on a DNA
synthesizer (Applied Biosystem Model 391A) by using a
slightly modified 1-µmol-scale cycle in the “trityl off” mode.
The 1-µmol-scale cycle supplied by ABI was modified in the
following manner: phosphoramidite coupling, a 300-s “wait”
for 5′-O-(dimethoxytrityl)thymidine 3′-O-(2-cyanoethyl N,N-
diisopropylphosphoramidite) and N6-benzoyl-5′-O-(dimethoxy-
trityl)adenosine 3′-O-(2-cyanoethyl N,N-diisopropylphosphora-
midite) and a 600-s “wait” for 11. A 0.025 M solution of 11 in
CH3CN was used in the branching step. Controlled-pore glass
(CPG, 500-Å pore size, Funakoshi Co.) was used as a solid
support. The ODN (1 µmol) linked to the solid support was
treated with concentrated NH4OH (2 mL) at 55 °C for 16 h.
The ammoniacal solutions of ODNs were concentrated under
reduced pressure. The crude ODNs were purified by 20%
polyacrylamide gel electrophoresis under denaturing condi-
tions (7 M urea), followed by reversed-phase HPLC. The
deprotected ODNs 1 and 3 were obtained in 19 and 21 OD260
units, respectively. Similarly, ODNs 2 and 4 were obtained in
17 and 16 OD260 units, respectively.
1,3-O-Bis(ter t-bu tyldiph en ysilyl)-2,2-bis[[[N-(3-h ydr oxy-
p r op yl)ca r ba m oyl]oxy]m eth yl]-1,3-p r op a n ed iol (7). N,N-
Carbonyldiimidazole (9.73 g, 60.0 mmol) and DMAP (370 mg,
3.00 mmol) were added to a solution of 6b (9.19 g, 15.0 mmol)
in DMF (50 mL), and the mixture was stirred at room
temperature. After 40 min, 3-amino-1-propanol (17.2 mL, 225
mmol) was added to the mixture, and the whole was stirred
at room temperature for 1 h. The mixture was concentrated
in vacuo and was taken in AcOEt, which was washed with
H2O and brine. The separated organic phase was dried (Na2-
SO4) and concentrated to dryness. The residue was purified
by column chromatography (SiO2, 1% MeOH in CHCl3) to give
7 (10.9 g, 88%): mp 148-149 °C; 1H NMR (CDCl3) δ 7.64-
7.31 (m, 20H), 4.69 (br s, 2H, J ) 5.8, D2O exchangeable), 4.09
(s, 4H), 3.67 (s, 4H), 3.62 (m, 4H), 3.28 (m, 4H), 2.80 (br s, 2H,
D2O exchangeable), 1.65 (m, 4H), 1.02 (s, 18H); 13C NMR
(CDCl3, 13C signals were assigned on the basis of DEPT
experiment) δ 157.2 (C), 135.7 (CH), 133.2 (C), 129.7 (CH),
127.7 (CH), 65.9 (CH2), 61.4 (CH2), 59.4 (CH2), 50.5 (CH3), 45.8
(C), 37.4 (CH2), 32.5 (CH2), 26.9 (CH3), 19.3 (C); HRMS (FAB)
calcd for C45H63Ν2O8Si2 815.4119, found 815.4087. Anal. Calcd
for C45H62N2O8Si2: C, 66.30; H, 7.67; N, 3.44. Found: C, 66.32;
H, 7.68; N, 3.66.
2,2-Bis[[[N-[3-O-(4,4′-d im et h oxyt r it yloxy)p r op yl]ca r -
ba m oyl]oxy]m eth yl]-1,3-p r op a n ed iol (9). A mixture of 7
(10.0 g, 12.3 mmol) and DMTrCl (9.17 g, 27.1 mmol) in
pyridine (50 mL) was stirred at room temperature for 1 h.
EtOH (15 mL) was added to the mixture, and the whole was
stirred for 10 min. The mixture was evaporated under reduced
pressure. The residue was taken in AcOEt, which was washed
with saturated aqueous NaHCO3 and brine. The separated
organic phase was dried (Na2SO4) and concentrated to dryness.
The residue was dissolved in THF (50 mL). TBAF (1 M in THF,
50 mL, 50 mmol) was added to the solution, and the resulting
mixture was stirred overnight at room temperature. The
mixture was evaporated under reduced pressure and was
taken in AcOEt, which was washed with H2O and brine. The
separated organic phase was dried (Na2SO4) and concentrated
to dryness. The residue was purified by column chromatog-
raphy (SiO2, 0-2% MeOH in CHCl3) to give 9 (9.88 g, 85%):
Electr osp r a y Ion iza tion Ma ss Sp ectr om etr y. Spectra
were obtained on a Quattro II (Micromass, Manchester, UK)
triple quadrupole mass spectrometer equipped with an ESI
source in the negative ion mode. The HPLC-purified ODN
samples were dissolved in aqueous 50% 2-propanol containing
1% triethylamine (10 pmol ODN/µL) and introduced into the
1
mp 148-149 °C; H NMR (DMSO-d6) δ 7.37-7.21 (m, 18H),
6.97 (br s, 2H, D2O exchangeable), 6.89-6.86 (m, 8H), 4.44
(br s, 2H, D2O exchangeable), 3.88 (s, 4H), 3.72 (s, 12H), 3.36